The effect of nutritional intervention on the lipid profile and dietary intake of adolescents with juvenile systemic lupus erythematosus: a randomized,controlled trial
Restricted accessResearch articleFirst published online April, 2018
The effect of nutritional intervention on the lipid profile and dietary intake of adolescents with juvenile systemic lupus erythematosus: a randomized,controlled trial
This study sought to evaluate the effects of a nutritional intervention on the lipid metabolism biomarkers associated with cardiovascular risk, and their variation over time, in juvenile systemic lupus erythematosus (JSLE) patients. This study also investigated the relationships between these biomarkers and dietary intake, nutritional status, disease variables, and medication used.
Methods
A total of 31 10- to 19-year-old female adolescents with JSLE for at least six months were analyzed. The participants were randomly allocated to two groups: nutritional intervention or control. The intervention group received verbal and printed nutritional instructions once per month over nine months. Before and after the intervention, the participants underwent assessments of anthropometry; dietary intake; physical activity; socioeconomic status; total cholesterol and fractions; triglycerides; apolipoprotein A (Apo A-I); apolipoprotein B (Apo B); paraoxonase (PON) activity (a) and amount (q); myeloperoxidase (MPO); and small, dense LDL-c (sdLDL) particles.
Results
After nine months, we found significant reductions in the calorie, carbohydrate, total fat, saturated fat, and trans fat intakes in the intervention compared with the control group over time. The PONa/HDL-c ratio increased by 3.18 U/ml/mg/dl in the intervention group and by 0.63 U/ml/mg/dl in the control group (p = 0.037). Unlike the intervention group, the sdLDL levels of the control group worsened over time (p = 0.018).
Conclusion
The present study detected a reduction in calorie and fat intake, which indicates an improvement of HDL-c function and possible protection against cardiovascular risk for the intervention group.
RoifmanIBeckPLAndersonTJEisenbergMJGenestJ. Chronic inflammatory diseases and cardiovascular risk: A systematic review. Can J Cardiol2011; 27: 174–182.
2.
HayataALBorbaEFBonfáEKochenJAGoldenstein-SchainbergC. The frequency of high/moderate lipoprotein risk factor for coronary artery disease is significant in juvenile-onset systemic lupus erythematosus. Lupus2005; 14: 613–617.
3.
ArdoinSPSandborgCSchanbergLE. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus. Lupus2007; 16: 618–626.
4.
BichileTPetriM. Prevention and management of co-morbidities in SLE. Presse Med2014; 43(6 Pt 2): e187–e195.
Posadas-RomeroCTorres-TamayoMZamora-GonzálezJet al.High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus. Arthritis Rheum2004; 50: 160–165.
7.
SoepJBMietus-SnyderMMalloyMJWitztumJLvon SchevenE. Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus. Arthritis Rheum2004; 51: 451–457.
8.
TripiLMManziSChenQet al.Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus. Arthritis Rheum2006; 54: 1928–1939.
9.
KissESeresITarrTKocsisZSzegediGParaghG. Reduced paraoxonase 1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus. Ann N Y Acad Sci2007; 1108: 83–91.
DasguptaSDemirciFYDressenASet al.Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus. BMC Med Genet2011; 12: 7.
12.
EverettSTWolfRContentoIHaiducVRicheyMErkanD. Short-term patient-centered nutrition counseling impacts weight and nutrient intake in patients with systemic lupus erythematosus. Lupus2015; 24: 1321–1326.
13.
ShahMKavanaughACoyleYAdams-HuetBLipskyPE. Effect of a culturally sensitive cholesterol lowering diet program on lipid and lipoproteins, body weight, nutrient intakes, and quality of life in patients with systemic lupus erythematosus. J Rheumatol2002; 29: 2122–2128.
14.
Hearth-HolmesMBaethgeBABroadwellLWolfRE. Dietary treatment of hyperlipidemia in patients with systemic lupus erythematosus. J Rheumatol1995; 22: 450–454.
15.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725.
16.
SaghaeiM. Random Allocation software for parallel group randomized trials. BMC Med Res Methodol2004; 4: 26.
17.
SantosRDGagliardiACMXavierHTet al.I Diretriz sobre o consumo de gorduras e saúde cardiovascular (First guidelines of fat consumption and cardiovascular health) [article in Portuguese]. Arq Bras Cardiol2013; 100(1 Suppl 3): 1–40.
18.
GiddingSSDennisonBABirchLLet al.Dietary recommendations for children and adolescents: A guide for practitioners: Consensus statement from the American Heart Association. Circulation2005; 112: 2061–2075.
19.
Institute of Medicine. Dietary reference intakes: Applications in dietary assessment, Washington: National Academy Press, 2003.
20.
World Health Organization. Anthro Plus for personal computers manual: Software for assessing growth of the world's children and adolescents, Geneva: WHO, 2009.
21.
de OnisMOnyangoAWBorghiESiyamANishidaCSiekmannJ. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ2007; 85: 660–667.
22.
MarshallWATannerJM. Variations in pattern of pubertal changes in girls. Arch Dis Child1969; 44: 291–303.
23.
NelsonNAssessment of food consumption and nutrient intake: Past intake. In: MargettsBMNelsonM (eds). Design concepts in nutritional epidemiology, New York: Oxford University Press, 1991, pp. 167–184.
24.
Anção M, Cuppari L, Draibe A, Sigulem D. Programa de apoio à nutrição-NutWin versão 1.5 (CD-ROM). São Paulo: Department of Informatic in Health, SPDM-UNIFESP, 2002.
25.
Tabela Brasileira de Composição de Alimentos. Tabela Brasileira de Composição de Alimentos (Brazilian list of food composition), 4th ed. Nepa-Unicamp: Campinas, 2011.
GladmanDGinzlerEGoldsmithCet al.The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum1996; 39: 363–369.
28.
JenovesiJFBraccoMMColugnatiFABTaddeiJA. Evolução no nível de atividade física de escolares observados pelo período de 1 ano (One year follow-up of physical activity level in scholars) [article in Portuguese]. Rev Bras Ciênc Mov2001; 12: 19–24.
29.
ABEP. Critério de classificação econômica do Brasil (Socioeconomic classification criteria in Brazil). São Paulo: Associação nacional de empresas de pesquisas (National associations of research companies), http://www.abep.org/criterio-brasil (2012, accessed 10 January 2013).
30.
GiulianoICCaramelliBPellandaLDuncanBMattosSFonsecaFH. I Diretriz de prevenção da aterosclerose na infância e na adolescência (I Guidelines of atherosclerosis prevention in childhood and adolescence) [article in Portuguese]. Arq Bras Cardiol2005; 85(Suppl 6): 4–36.
31.
MatthewsDRHoskerJPRudenskiASNaylorBATreacherDFTurnerRC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia1985; 28: 412–419.
32.
DanielsSRGreerFR, Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics2008; 122: 198–208.
33.
SrinivasanSRFrontiniMGXuJBerensonGS. Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: The Bogalusa Heart Study. Pediatrics2006; 118: 201–206.
34.
HoMGarnettSPBaurLet al.Effectiveness of lifestyle interventions in child obesity: Systematic review with meta-analysis. Pediatrics2012; 130: e1647–e1671.
35.
MalattiaCMartiniA. Paediatric-onset systemic lupus erythematosus. Best Pract Res Clin Rheumatol2013; 27: 351–362.
36.
DavisJNVenturaEETungAet al.Effects of a randomized maintenance intervention on adiposity and metabolic risk factors in overweight minority adolescents. Pediatr Obes2012; 7: 16–27.
37.
HahnBHGrossmanJAnsellBJSkaggsBJMcMahonM. Altered lipoprotein metabolism in chronic inflammatory states: Proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther2008; 10: 213–228.
38.
KowalskaKSochaEMilnerowiczH. Review: The role of paraoxonase in cardiovascular diseases. Ann Clin Lab Sci2015; 45: 226–233.
39.
MillerMStoneNJBallantyneCet al.Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association. Circulation2011; 123: 2292–2333.
40.
SilvermanEEddyASystemic lupus erythematosus. In: CassidyJTPettyRELaxerRMLindsleyCB (eds). Textbook of pediatric rheumatology, 5th ed. Philadelphia: Elsevier Saunders, 2011, pp. 315–343.
